Dr. Park joined SCYNEXIS in 2017 as Executive Director, Regulatory Affairs. He has more than 30 years of experience in the pharmaceutical/biotech/medical device industry in clinical development and regulatory affairs. Dr. Park has led global clinical development of medical products across multiple therapeutic areas, including diabetes, hypertension, Gaucher disease, Fabry disease, renal disease, head lice, and chemotherapy-induced alopecia. He has had primary authorship responsibility for the clinical section of multiple NDAs and managed numerous investigational and marketing applications and regulatory communications with CDER, CBER, and CDRH. Dr. Park received his Doctor of Pharmacy degree from the University of Missouri-Kansas City and a Master of Science in Jurisprudence degree from Seaton Hall Law School.

Source: SCYNEXIS, Inc. on 12/28/2022